BioLaurus, Inc.

Biolaurus is an innovator in preclinical safety/tox study design and execution. Learn more and get a quote below. https://biolaurus.com//function-imaging-in-safety-toxicol/

BioLaurus, Inc. and Triangulum Biopharma have collaborated to develop an Ultrasound method to measure NASH in the CDAHFD model of liver fibrosis in mice. Learn more about how we did it below! #lifesciences #biotech #preclinical https://biolaurus.com/molecular-im/nash-ultrasound-imaging/

The development of new investigative therapeutics requires animal models that reproduce the disease. Learn how BioLaurus, Inc. applies the latest imaging technologies to cardiomyopathy studies. https://biolaurus.com//echocardiography-model-of-cardiomy/ #lifescience #drugdevelopment #biopharma

The first opioid receptor assay ever developed targeted mu-opioid receptors (MOR) with the ligand C-11 carfentanil (CFN). With this assay PK data can be determined from time activity curves (TAC). #drugdevelopment #biotechnology #lifesciences https://biolaurus.com/molecul/opioid-receptor-occupancy-pk/

BioLaurus, Inc. is a leader in molecular imaging studies and assay development. Learn about our approach to PK analasys and tox studies by reading our latest article: https://biolaurus.com//drug-induced-thrombocytopenia-pk-a/ #lifesciences #biotechnology #drugdevelopment

Molecular Imaging Examples